Target intelligence / Profile preview

Elongin C pseudogene 33 (ELOCP33)

Target: ELOCP33
Molecular classification: Other

Overview

Elongin C pseudogene 33 (ELOCP33) is annotated as a pseudogene, meaning it is a non-functional segment of DNA that resembles the coding gene for elongin C (ELOC) but does not encode a protein or have known biological activity. Pseudogenes generally do not produce functional protein products and are not considered therapeutic targets or druggable genes. There is no evidence to suggest that ELOCP33 has any biological, pathological, or therapeutic relevance[7].

Beyond the preview

Go deeper on Elongin C pseudogene 33 (ELOCP33).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongin C pseudogene 33 (ELOCP33).

Explore the full profile